$DNA stock has now fallen 12% today, according to our price data from Polygon. There has been approximately $25,398,594 of trading volume.
Here is what we see in our data on $DNA (you can track the company live on Quiver's $DNA stock page):$DNA Insider Trading Activity
$DNA insiders have traded $DNA stock on the open market 8 times in the past 6 months. Of those trades, 0 have been purchases and 8 have been sales.
Here’s a breakdown of recent trading of $DNA stock by insiders over the last 6 months:
- STEVEN P. COEN (See remarks) has made 0 purchases and 5 sales selling 3,132 shares for an estimated $27,448.
- MARK E. DMYTRUK (See remarks) has made 0 purchases and 3 sales selling 2,740 shares for an estimated $20,517.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$DNA Hedge Fund Activity
We have seen 0 institutional investors add shares of $DNA stock to their portfolio, and 1 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JPL WEALTH MANAGEMENT, LLC removed 10,000 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $112,500
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$DNA Government Contracts
We have seen $65,574,626 of award payments to $DNA over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- TRAVELER-BASED GENOMIC SURVEILLANCE PROGRAM: $53,725,682
- AIRPORT GENOMIC TESTING: $7,774,961
- TEST SURGE AND DATA SHARING MULTIPLE AWARD IDIQ: $1,236,101
- DARPA ICE CONTROL FOR COLD ENVIRONMENTS (ICE): $1,191,941
- TEST SURGE AND DATA SHARING MULTIPLE AWARD IDIQ: $775,180
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
You can track data on $DNA on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.